Rheumatology Medical News about systemic sclerosis; serotonin 5-HT2A receptor gene

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation
Arthritis Research & Therapy, 09/05/08

Beretta L et al. – The His452Tyr substitution may influence susceptibility to systemic sclerosis by altering platelet aggregation in response to 5-HT.

Methods

Aim was to to determine if His452Tyr substitution, was associated with blunted intracellular responses after serotonin stimulation and may have a role in susceptibility to scleroderma
115 consecutive SSc pts and 140 well-matched healthy controls
Subjects were genotyped for the His452Tyr substitution of the serotonin 2A receptor gene
The associations were sought with scleroderma and its main clinical features
Aggregation of platelet-rich plasma from His452/His452 and His452/Tyr452 healthy individuals were assessed after stimulation with adenosine diphosphate +/- serotonin

Results

The T allele of the C+1354T polymorphism was underrepresented in scleroderma pts
Its carriage reduced the risk for SSc
Platelets from His452/Tyr452 healthy subjects more weakly responded to serotonin stimulation vs His452/His452 individuals

<< Previous
Potential effects of chondroitin sulfate on joint swelling: A...

Next >>
The relationship between inflammation and new bone formation in...